B cells and antibodies as targets of therapeutic intervention in neuromyelitis optica spectrum disorders
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Pharmaceuticals (2021) 14:1, 37. https://doi.org/10.3390/ph14010037
- Event
-
Veröffentlichung
- (where)
-
Würzburg
- (who)
-
Universität Würzburg
- (when)
-
2022
- Creator
-
Traub, Jan
Husseini, Leila
Weber, Martin S.
- DOI
-
10.3390/ph14010037
- URN
-
urn:nbn:de:bvb:20-opus-222957
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:49 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Traub, Jan
- Husseini, Leila
- Weber, Martin S.
- Universität Würzburg
Time of origin
- 2022
Other Objects (12)
Therapeutic antibodies
Therapeutic antibodies
Afferent visual system changes in patients with Neuromyelitis Optica Spectrum Disorders
Handbook of therapeutic antibodies, Vol. 3.. Approved therapeutic antibodies
Influence of female sex and fertile age on neuromyelitis optica spectrum disorders
A multicenter study on outer retinal layer changes in neuromyelitis optica spectrum disorders
Handbook of therapeutic antibodies, Vol. 4.. Approved therapeutic antibodies and in vivo diagnostics
Handbook of therapeutic antibodies, Vol. 2.. Clinical development of antibodies
Editorial: Effector functions of therapeutic antibodies
Interleukin-6 receptor blockade in treatment-refractory MOG-IgG–associated disease and neuromyelitis optica spectrum disorders
Spinal cord atrophy measured from cerebral T1-weighted MRI: applications in clinical investigations of neuromyelitis optica spectrum disorders
Special issue Humor in autism spectrum disorders
Therapeutic antibodies
Therapeutic antibodies
Afferent visual system changes in patients with Neuromyelitis Optica Spectrum Disorders
Handbook of therapeutic antibodies, Vol. 3.. Approved therapeutic antibodies
Influence of female sex and fertile age on neuromyelitis optica spectrum disorders
A multicenter study on outer retinal layer changes in neuromyelitis optica spectrum disorders
Handbook of therapeutic antibodies, Vol. 4.. Approved therapeutic antibodies and in vivo diagnostics
Handbook of therapeutic antibodies, Vol. 2.. Clinical development of antibodies
Editorial: Effector functions of therapeutic antibodies
Interleukin-6 receptor blockade in treatment-refractory MOG-IgG–associated disease and neuromyelitis optica spectrum disorders
Spinal cord atrophy measured from cerebral T1-weighted MRI: applications in clinical investigations of neuromyelitis optica spectrum disorders
Special issue Humor in autism spectrum disorders
Therapeutic antibodies
Therapeutic antibodies
Afferent visual system changes in patients with Neuromyelitis Optica Spectrum Disorders
Handbook of therapeutic antibodies, Vol. 3.. Approved therapeutic antibodies
Influence of female sex and fertile age on neuromyelitis optica spectrum disorders
A multicenter study on outer retinal layer changes in neuromyelitis optica spectrum disorders
Handbook of therapeutic antibodies, Vol. 4.. Approved therapeutic antibodies and in vivo diagnostics
Handbook of therapeutic antibodies, Vol. 2.. Clinical development of antibodies
Editorial: Effector functions of therapeutic antibodies
Interleukin-6 receptor blockade in treatment-refractory MOG-IgG–associated disease and neuromyelitis optica spectrum disorders
Spinal cord atrophy measured from cerebral T1-weighted MRI: applications in clinical investigations of neuromyelitis optica spectrum disorders